BioMed Research International

Helicobacter pylori and Pathogenesis


Publishing date
15 May 2015
Status
Published
Submission deadline
26 Dec 2014

Lead Editor

1Tokyo Medical University, Tokyo, Japan

2Kyorin University School of Medicine, Tokyo, Japan

3Keio University School of Medicine, Tokyo, Japan


Helicobacter pylori and Pathogenesis

Description

Helicobacter pylori is a causative agent for chronic gastritis, peptic ulcer diseases, gastric cancer, and MALT lymphoma. In addition, an association of extragastric diseases including idiopathic thrombocytopenic purpura, iron deficiency anemia, atopic dermatitis, and so on with H. pylori is reported. Eradication therapy using a combination regimen with proton pump inhibitor and antimicrobial agents for H. pylori infection has been established, and it is now possible by the therapy to prevent malignant diseases including gastric cancer. However, the details on the mechanism(s) by which H. pylori infection induces pathogenesis in humans remain to be determined.

We invite authors to submit original research and review articles that seek to clarify pathogenic role of H. pylori. We are interested in articles that explore aspects of pathogenesis caused by H. pylori infection. In addition, translational researches from basic studies to development of innovative diagnostic procedures and clinical treatments are expected to be submitted.

Potential topics include, but are not limited to:

  • Microbiology of H. pylori
  • Strain diversity of H. pylori strains
  • Omics of H. pylori infection
  • Animal model of H. pylori infection
  • Virulence factors of H. pylori
  • Mucosal immunity and of H. pylori infection
  • Carcinogenesis by H. pylori infection
  • Translational studies for diagnosis and clinical treatment of H. pylori infection

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 304768
  • - Editorial

Helicobacter pylori and Pathogenesis

Akio Tomoda | Shigeru Kamiya | Hidekazu Suzuki
  • Special Issue
  • - Volume 2015
  • - Article ID 794378
  • - Review Article

Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy

Toshihiro Nishizawa | Hidekazu Suzuki
  • Special Issue
  • - Volume 2015
  • - Article ID 753710
  • - Research Article

Prevalence of Helicobacter pylori vacA, cagA, and iceA Genotypes in Cuban Patients with Upper Gastrointestinal Diseases

Onelkis Feliciano | Oderay Gutierrez | ... | Rafael Llanes
  • Special Issue
  • - Volume 2015
  • - Article ID 192420
  • - Review Article

Interplay of the Gastric Pathogen Helicobacter pylori with Toll-Like Receptors

Suneesh Kumar Pachathundikandi | Judith Lind | ... | Steffen Backert
  • Special Issue
  • - Volume 2015
  • - Article ID 354519
  • - Letter to the Editor

Comment on “Helicobacter pylori Outer Membrane Protein 18 (Hp1125) Is Involved in Persistent Colonization by Evading Interferon-γ Signaling”

Amin Talebi Bezmin Abadi | Enzo Ierardi
  • Special Issue
  • - Volume 2015
  • - Article ID 571280
  • - Research Article

Helicobacter pylori Outer Membrane Protein 18 (Hp1125) Is Involved in Persistent Colonization by Evading Interferon-γ Signaling

Yuqun Shan | Xingxiao Lu | ... | Jihui Jia
  • Special Issue
  • - Volume 2015
  • - Article ID 734548
  • - Research Article

Nordihydroguaiaretic Acid Disrupts the Antioxidant Ability of Helicobacter pylori through the Repression of SodB Activity In Vitro

Hitoshi Tsugawa | Hideki Mori | ... | Hidekazu Suzuki
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.